Prasugrel should be preferred over ticagrelor in acute coronary syndromes: pros and cons
EuroIntervention · 2026-05 · 22 (10) · 526-529
DOI: 10.4244/eij-e-26-00004 ↗Kurz gefasst
Fachartikel in der Zeitschrift EuroIntervention, 2026-05. Verfasst von Dominick J Angiolillo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, University of Florida College of Medicine, Jacksonville, FL, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Cardiology, University of Florida College of Medicine, Jacksonville, FL, USA.
- Department of Cardiology, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany and Deutsches, Zentrum für Herz-und Kreislauferkrankungen, partner site Munich Heart Alliance, Munich, Germany.
- Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland.
- Faculty of Biomedical Sciences, University of Italian Switzerland, Lugano, Switzerland.
- University of Bern, Bern, Switzerland.
Zitieren
APA
Angiolillo, D. J., Kastrati, A., Frazzetto, M., & Valgimigli, M. (2026). Prasugrel should be preferred over ticagrelor in acute coronary syndromes: pros and cons. EuroIntervention, 22(10), 526-529. https://doi.org/10.4244/eij-e-26-00004
Vancouver
Angiolillo DJ, Kastrati A, Frazzetto M, Valgimigli M. Prasugrel should be preferred over ticagrelor in acute coronary syndromes: pros and cons. EuroIntervention. 2026;22(10):526-529. doi:10.4244/eij-e-26-00004
BibTeX
@article{Angiolillo2026,
author = {Angiolillo, Dominick J and Kastrati, Adnan and Frazzetto, Marco and Valgimigli, Marco},
title = {Prasugrel should be preferred over ticagrelor in acute coronary syndromes: pros and cons},
journal = {EuroIntervention},
year = {2026},
volume = {22},
number = {10},
pages = {526--529},
doi = {10.4244/eij-e-26-00004}
}
EUVIMED